An epithelial-mesenchymal cell transformation occurs during the development of the endocardial cushions in the atrioventricular (AV) canal of the heart. We hypothesized that the transcription factor Slug is required for this epithelial-mesenchymal cell transformation since Slug is required for similar transformations during gastrulation and neural crest differentiation in chicken embryos. We found by RT-PCR and immunostaining that the temporal and spatial localization of Slug in the embryonic chicken heart is consistent with a role for Slug in endocardial cushion formation. Moreover, we found that Slug expression by AV canal endothelial cells is induced by a signal provided by AV canal myocardium. Slug appears to be required for epithelial-mesenchymal cell transformation in the chicken heart since treatment of AV canal explants with antisense Slug oligodeoxynucleotides inhibited mesenchymal cell formation in vitro. Antisense Slug oligodeoxynucleotides prevented endothelial cell-cell separation, suggesting that Slug acts early in the transformation pathway.
INTRODUCTION
Early in embryonic development, the vertebrate heart is a hollow tube composed of an outer myocardium and an inner endocardium separated by extracellular matrix (ECM).
1 As cardiac morphogenesis proceeds, endocardial cushions develop within the atrioventricular (AV) canal. Endocardial cushion tissue eventually contributes to the interatrial and interventricular septa, as well as to the leaflets of the tricuspid and mitral valves (Markwald et al., 1984; Chin et al., 1992) . Endocardial cushions initially consist of ECM material that is synthesized by AV canal myocardium (Krug et al., 1987) . Later, in response to an inductive signal emitted by AV canal myocardium (Runyan and Markwald, 1983; Krug et al., 1985 Krug et al., , 1987 , a portion of the endothelial cells lining the endocardial cushions undergo an epithelial-mesenchymal cell transformation and migrate into the underlying ECM (Kinsella and Fitzharris, 1980) .
Although the epithelial-mesenchymal cell transformation that occurs during endocardial cushion formation is well characterized at a morphological level, the underlying molecular mechanisms are poorly understood. Similar epithelial-mesenchymal cell transformations occur during other developmental processes including gastrulation, neural crest differentiation, Mullerian duct degeneration, and fusion of the palatal shelves (Hay, 1995) . Previous studies suggest that the transcription factor Slug is required for several of these epithelial-mesenchymal cell transformations in chicken embryos (Nieto et al., 1994) . Consequently, we hypothesized that Slug plays a role in the epithelial-mesenchymal cell transformation that occurs during endocardial cushion formation in the AV canal. Slug is a zinc finger protein of the Snail family (Nieto et al., 1994) , whose members derive their unusual names from the anatomical phenotype produced when the snail gene is mutated in Drosophila (Boulay et al., 1987) . Slug expression was detected by whole-mount in situ hybridization in the epiblast cells flanking the primitive streak of the chicken embryo (Nieto et al., 1994) . These cells continue to express Slug as they transform into mesoderm and migrate down into the blastocoel during gastrulation. Slug expression also was detected, except at the most anterior end of the embryo, in cells at the edge of the neural plate (Nieto et al., 1994) . These cells eventually migrate from the dorsal region of the neural tube as mesenchyme, following defined neural crest pathways. When stage 4 -9 chicken embryos were cultured in vitro in the presence of antisense Slug oligodeoxynucleotides, mesoderm formation was impaired (Nieto et al., 1994) . Likewise, presumptive neural crest cells failed to transform into mesenchyme, resulting in a wide range of defects.
More recent studies also point toward a conserved role for Slug in epithelial-mesenchymal cell transformations. For instance, Slug expression was detected by whole-mount in situ hybridization in the premigratory neural crest of Xenopus embryos (Mayor et al., 1995) . In addition, NBT-II cells transfected with mouse Slug cDNA were induced to undergo initial steps of epithelial-mesenchymal cell transformation in vitro (Savagner et al., 1997) . NBT-II cells also can be induced by fibroblast growth factor-1 (FGF-1) or hepatocyte growth factor (HGF) to transform into mesenchymal cells (Valles et al., 1990; Savagner et al., 1997) . However, NBT-II cells transfected with antisense Slug cDNA resisted induction by FGF-1 or HGF (Savagner et al., 1997) .
To investigate the potential role of Slug in the epithelialmesenchymal cell transformation that occurs in the AV canal, we analyzed Slug expression in the chicken embryo heart at the mRNA and protein levels by reverse transcription-polymerase chain reaction (RT-PCR) and immunostaining. We found that the temporal and spatial expression of Slug in the heart is consistent with a role for this transcription factor in endocardial cushion formation. Moreover, we found that Slug expression by AV canal endothelial cells is induced by a signal provided by AV canal myocardium. To determine if Slug functions during transformation, we cultured AV canal explants in vitro in the presence of antisense Slug oligodeoxynucleotides. Antisense treatment inhibited mesenchymal cell formation, suggesting that Slug plays a role in epithelial-mesenchymal cell transformation in the heart, as well as in other developing tissues.
MATERIALS AND METHODS

RT-PCR
Fertilized White Leghorn chicken eggs were obtained from Rosemary's Farm (Santa Monica, CA) and incubated at 37°C to obtain embryos, which were staged according to Hamburger and Hamilton (1951) . Total RNA was extracted from stage 14, 16, 17, 18, and 20 chicken embryos using RNA Stat-60 (Tel-Test "B", Inc., Friendswood, TX) and treated with DNase (Gibco BRL, Gaithersburg, MD). The total volume for each reverse transcription reaction was 30 l for 2 g of RNA. The reaction also included 1.5 l of random primers (Gibco BRL), 1 l of 10 mM dNTPs (Gibco), 20 U of rRNasin RNase inhibitor (Promega, Madison, WI), and 400 U of M-MLV Reverse Transcriptase in 5ϫ First Strand Buffer supplied with the enzyme (Gibco BRL). cDNA was synthesized in a PTC-100 Programmable Thermal Controller (MJ Research, Inc., Watertown, MA) under the following conditions: a 1.5-h incubation at 37°C and a 10-min incubation at 75°C.
Specific primers were designed for PCR based on the published chicken Slug sequence (Nieto et al., 1994) . The primer sequences were 5Ј CTGCCTTCAAAATGCCAC (bp 1-14) and 3Ј TTGGACT-GGATTCTCTCT (bp 341-358). The total volume for each PCR was 50 l. The reaction included 0.1 g of each specific primer (Integrated DNA Technologies, Inc., Coralville, IA), 0.1 g of cDNA, 1 l of 10 mM dNTPs, 3 l of 25 mM magnesium chloride (Fisher Scientific, Pittsburgh, PA), and 2.5 U of Taq DNA polymerase in 10ϫ Assay Buffer B supplied with the enzyme (Fisher Scientific). PCR was performed for 36 cycles in a PTC-100 Programmable Thermal Controller under the following conditions: 30 s of denaturation at 92°C, 1 min of annealing at 58°C, and 1.5 min extension at 72°C. The 358-bp PCR product was fractionated on a 1% agarose gel and visualized using ethidium bromide. As a control for loading, RT-PCR also was performed using specific primers designed to amplify an 800-bp glyceraldehyde 3-phosphate dehydrogenase (GAPDH) sequence.
Immunoprecipitation
Chicken embryos between stages 14 and 18 of development were minced by placing tissue fragments between the frosted ends of two glass microscope slides and gently rubbing the slides together. Chicken Slug protein was immunoprecipitated according to Fowler et al. (1993) with the following modifications: 20 g of a monoclonal anti-chicken Slug antibody (provided by Dr. Thomas Jessell at Columbia University, New York; now available from the Developmental Studies Hybridoma Bank, Iowa City, IA) was added to GammaBand Plus Sepharose Beads (Pharmacia Biotech, Uppsala, Sweden). Immunoprecipitation using beads in the absence of antibody served as a negative control. Samples were loaded on a 12% PAGE gel and transferred to nitrocellulose. The nitrocellulose was baked at 60°C for 45 min and stained with Ponceau S (Gelman Instrument Co., Ann Arbor, MI) to visualize chicken Slug protein.
Coomassie blue did not adequately stain chicken Slug protein in the gel (data not shown).
Immunostaining
Stage 17 chicken embryo thoraxes were frozen in liquid nitrogen-cooled isopentane and placed in plastic scintillation vials filled with 100% ethanol (EtOH). The vials were stored in a Ϫ80°C freezer for at least 5 days before the tissue was embedded in paraffin. After the EtOH substitution, the tissue was rinsed twice with 100% EtOH for 5 min and cleared by rinsing three times with xylene for 10 min. After the tissue was incubated in a 1:1 mixture of xylene and paraffin for 20 min, the tissue was incubated in 100% paraffin for 1 h at 55°C. The tissue was then transferred to plastic molds, positioned, and cooled. Once embedded in paraffin, 7-m sections of tissue were cut with a microtome and transferred to glass slides. The slides were stored at 4°C prior to use.
After the slides were immersed in xylene for 2 min, the tissue was rehydrated in an EtOH series and rinsed for 1 h in 1ϫ PBS at 4°C. To block nonspecific binding sites, 1ϫ PBS containing 0.1% dried milk and 1% donkey serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) was applied to the sections for 30 min at 37°C in a humidified chamber. A monoclonal anti-chicken Slug antibody was diluted 1:100 in the blocking solution and centrifuged at 12,000 rpm for 1 h. The primary antibody was applied to the sections overnight at 4°C. Alternatively, mouse IgG (Jackson ImmunoResearch Laboratories, Inc.) (1 g/ml) diluted in the blocking solution was applied to some of the sections as a negative control. After incubation with the primary antibody, the slides were rinsed with 1ϫ PBS containing 0.2% Tween (Sigma, St.
Louis, MO) for 30 min or longer. AffiniPure Rabbit Anti-Mouse IgG (H ϩ L) (Jackson ImmunoResearch Laboratories, Inc.) (20 g/ml) was diluted in the blocking solution containing 1% chicken serum (Sigma) and centrifuged at 12,000 rpm for 1 h. The secondary antibody was applied to the sections for 30 min at room temperature. After incubation with the secondary antibody, the slides were rinsed as previously described. Finally, Cy5-conjugated AffiniPure Goat Anti-Rabbit IgG (H ϩ L) (Jackson ImmunoResesarch Laboratories, Inc.) was diluted 1:200 in the blocking solution containing 1% chicken serum and centrifuged at 12,000 rpm for 1 h. The tertiary antibody was applied to the sections for 30 min at room temperature. After incubation with the tertiary antibody, the slides were rinsed as previously described. Coverslips were mounted using glycerol gelatin and sealed with nail polish. The slides were stored in the dark at 4°C until viewed under a Leica confocal microscope.
In Vitro Immunostaining
Collagen gels were prepared as follows: 1 ml of rat tail collagen diluted 1:1 in water was mixed with 200 l of 2.2% sodium bicarbonate diluted 1:1 in 10ϫ Media 199 (Gibco BRL). Then 280 l of the collagen solution was poured into each well of a Nunclon MultiDish culture dish (Nunc, Roskilde, Denmark) and allowed to solidify for at least 15 min at room temperature. Then 500 l of medium was applied to the collagen gels for at least 1 h at 37°C in the tissue culture incubator prior to use.
The AV canal was dissected from stage 14 chicken embryos and placed on collagen gels so that the endocardium was in contact with the surface of the gel to facilitate endothelial cell outgrowth. The myocardium was removed from several of the explants after 9 h of incubation at 37°C in a Revco Ultima tissue culture incubator. After 24 h of incubation, the explants were rinsed with Tyrode's solution (Sigma) for 30 min at room temperature and fixed with 2% paraformaldehyde for 40 min at room temperature. After fixation, the explants were rinsed with 1ϫ PBS for 1 h at room temperature. To block nonspecific binding sites, 1ϫ PBS containing 1% bovine serum albumin and 2% donkey serum (Jackson ImmunoResearch Laboratories, Inc.) was applied to the explants for 30 min at 37°C. Blocking solution containing 0.2% Tween was then applied to the explants overnight at 4°C. A monoclonal anti-chicken Slug antibody was diluted 1:100 in 1ϫ PBS containing 0.5% bovine serum albumin (Sigma), 1% donkey serum (Jackson ImmunoResearch Laboratories, Inc.), and 0.2% Tween and applied to the sections for 2 h at 4°C. Alternatively, mouse IgG (Jackson ImmunoResearch Laboratories, Inc.) (1 g/ml) diluted in 1ϫ PBS containing 0.5% bovine serum albumin (Sigma), 1% donkey serum (Jackson ImmunoResearch Laboratories, Inc.), and 0.2% Tween was applied to some of the explants as a negative control. After incubation with the primary antibody, the slides were rinsed with 1ϫ PBS containing 0.2% Tween for 2 h at room temperature. AffiniPure Rabbit Anti-Mouse IgG (H ϩ L) (Jackson ImmunoResearch Laboratories, Inc.) (10 g/ml) was diluted in 1ϫ PBS containing 0.2% Tween and applied to the explants for 30 min at 4°C. After incubation with the secondary antibody, the explants were rinsed as previously described. Finally, Cy5-conjugated AffiniPure Goat Anti-Rabbit IgG (H ϩ L) was diluted 1:300 in 1ϫ PBS containing 0.2% Tween and applied to the explants for 45 min at 4°C. After incubation with the tertiary antibody, the slides were rinsed with 1ϫ PBS containing 0.2% Tween for 2 h at room temperature and then with 1ϫ PBS for 30 min at room temperature. After the explants were rinsed with water, the collagen gels were transferred to glass slides. Coverslips were mounted using glycerol gelatin and sealed with nail polish. The slides were stored in the dark at 4°C until viewed under a Leica confocal microscope.
Oligodeoxynucleotide Treatment
The antisense oligodeoxynucleotide sequences were A, AG-GAAGGAGCGTGGC (bp 3-17); B, ATATAATCACTGTAT (bp 74 -88); C, TCCTTGTCACAGTAC (bp 497-511); and D, TG-CATCTTAAGTGCT (bp 527-541). Control oligodeoxynucleotide sequences corresponded to A, B, C, and D and were sense sequences in a reversed, 3Ј to 5Ј direction; A, TCCTTCCTCGCACCG; B, TATATTAGTGACATA; C, AGGAACAGTGTCATG; and D, ACGTAGAATTCACGA. These control oligodeoxynucleotide sequences were chosen to provide GC compositions identical to those of the corresponding antisense oligodeoxynucleotide sequences. In addition, reversed sense sequences do not perturb potential hairpin RNA structure such as may occur with direct sense sequences. A mixture of unmodified oligodeoxynucleotide (Integrated DNA Technologies, Inc.) and Lipofectamine Reagent (Gibco BRL) was prepared as follows: 6 g of oligodeoxynucleotide was diluted in 100 l of Media 199 (Gibco BRL). Six microliters of Lipofectamine Reagent also was diluted in 100 l of Media 199. The oligodeoxynucleotide and Lipofectamine Reagent solutions were mixed and incubated for 15 min at room temperature. An additional 800 l of Media 199 was then added to the mixture to produce a final concentration of 10 mM unmodified oligodeoxynucleotide.
AV canals were dissected from stage 14 chicken embryo hearts in Tyrode's solution (Sigma) and cut open to expose the inner endocardial surface. The explants were incubated in the mixture of oligodeoxynucleotide and Lipofectamine Reagent for 30 min at 37°C in a Revco Ultima tissue culture incubator. After 30 min of incubation in the presence of oligodeoxynucleotide, the explants were placed on collagen gels and returned to the tissue culture incubator. One microliter of additional oligodeoxynucleotide (6 g/l) was applied directly to the top of each explant 6 and 18 h after the explants were placed in culture. After 24 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant under an Olympus inverted microscope. Observation under the microscope also revealed that both control and antisense-treated explants were viable and that the myocardium was beating.
After 18 h of incubation, some of the treated explants were stained with a monoclonal anti-chicken Slug antibody as described above. Stained explants were stored in the dark at 4°C until viewed under a Leica confocal microscope.
After 24 h of incubation, RNA was isolated from selected explants and treated with DNase. RT-PCR was then performed using specific primers designed to amplify a 358-bp Slug sequence or an 800-bp GAPDH sequence from RNA collected from control explants as described above. The PCR products were fractionated on a 1% agarose gel and visualized using ethidium bromide. Band densities were quantitated using NIH Image analysis software. The background density of the gel was subtracted from the peak density for each band. The area of each band measured was then multiplied by the adjusted band density to determine relative amplification levels. Twenty-seven cycles was determined to be within the linear range of both Slug and GAPDH amplification by removing and analyzing aliquots from a series of cycles (20 -35). RT-PCR was then repeated for 27 cycles using RNA collected from both control and antisense-treated explants. Slug and GAPDH band densities were quantitated using NIH Image analysis software as described above. Slug band densities were normalized to GAPDH levels in the same RNA samples. The RT-PCR experiment was performed three times and average Slug band densities were obtained. The average Slug band densities obtained from AV canal explants treated with control oligodeoxynucleotides or with antisense Slug oligodeoxynucleotides were plotted relative to the average Slug band density obtained from AV canal explants treated with Lipofectamine alone, which was arbitrarily set at 1.
Statistical Analysis
A T test, Two-Sample Assuming Unequal Variances, was performed to compare control and antisense-treated groups of AV canal explants.
RESULTS
Slug Is Expressed in the Heart
We hypothesized that Slug plays a role in the epithelialmesenchymal cell transformation that occurs during endocardial cushion formation in the AV canal. To test our hypothesis, we began by examining Slug expression in the heart by RT-PCR. RT-PCR was performed using specific primers designed to amplify a 358-bp Slug sequence from DNase-treated heart RNA collected from chicken embryos between stages 14 and 20 of development. Stage 17 is the time at which epithelial-mesenchymal cell transformation becomes visible in the AV canal although AV canal endothelial cells begin to transform as early as stage 14 (Ramsdell and Markwald, unpublished observations). Furthermore, there are cells still in the process of transformation as late as stage 20 (Huang and Runyan, unpublished observations). The outflow tract was excluded from the dissections since neural crest cells, which contribute to this region of the heart, express Slug (Nieto et al., 1994) . A single band of the expected size was detected for each stage examined (Fig.  1) . RT-PCR performed with whole-embryo RNA collected from stage 17 embryos served as a positive control since Slug is known to be expressed in neural crest-derived tissue at this stage of development (Nieto et al., 1994) . RT-PCR performed without reverse transcriptase served as a negative control.
To further characterize the temporal and spatial localization of Slug protein in the heart, we stained sections of stage 17 chicken embryo thoraxes with a monoclonal antichicken Slug antibody. This antibody was previously used to stain cultured cells (Liem et al., 1997) . To confirm the specificity of the antibody, we performed immunoprecipitations with protein extract from chicken embryos between stages 14 and 18 of development. Gel electrophoresis followed by Ponceau S staining of immunoprecipitated protein revealed a single band that ran at 34 kDa (Fig. 2) .
Immunostaining of sections revealed that Slug is expressed by AV canal endothelial cells as well as by mesenchymal cells within the endocardial cushions (Fig. 3B) .
FIG. 1.
RT-PCR analysis of Slug expression in the heart at different developmental stages. RT-PCR was performed using specific primers designed to amplify a 358-bp Slug sequence from DNase-treated heart RNA collected from stage 14, 16, 17, 18, and 20 chicken embryos. RT-PCR using primers designed to amplify an 800-bp GAPDH sequence served as a control for loading. As a positive control (ϩ), RT-PCR was performed with whole-embryo RNA collected from stage 17 embryos since Slug is known to be expressed in neural crest-derived tissue at this stage of development. As a negative control (Ϫ), RT-PCR was performed without reverse transcriptase.
These mesenchymal cells are derived from the AV canal endothelium by an epithelial-mesenchymal cell transformation. Slug is expressed in AV canal endothelium and mesenchyme at slightly later developmental stages as well; however, virtually no staining was observed in the AV canal at stage 14 (data not shown). Slug also is expressed in the myocardium (Fig. 3D) , consistent with the fact that Slug expression recently was detected in this tissue by in situ hybridization (Savagner et al., 1998) . Staining was observed in the myocardium throughout the heart at all stages examined (data not shown). Finally, immunostaining revealed that Slug is expressed in the somites, another tissue in which epithelial-mesenchymal cell transformation occurs (Hay, 1995) . Specifically, staining was observed in the myotome (Fig. 3C ) and sclerotome (data not shown). Consistent with this observation, Slug expression was detected in the sclerotome of mouse embryos by in situ hybridization (Savagner et al., 1998) . 
Slug Expression by AV Canal Endothelial Cells Is Induced by a Signal Provided by AV Canal Myocardium
Previous studies demonstrated that AV canal endothelial cells undergo an epithelial-mesenchymal cell transformation representative of that observed in vivo when explanted onto collagen gels, provided AV canal myocardium or myocardium-conditioned medium is present (Runyan and Markwald, 1983) . After an AV canal explant is placed onto a collagen gel, the endothelial cells form a tight monolayer on the surface of the gel. In response to an inductive signal from AV canal myocardium, AV canal endothelial cells eventually lose contact with one another, transform into mesenchymal cells, and migrate down into the gel. Ventricular myocardium is not sufficient to induce the transformation of cultured AV canal endothelial cells (Mjaatveldt et al., 1987) . Furthermore, ventricular endothelial cells do not undergo transformation when cultured in the presence of AV canal myocardium (Krug et al., 1987) .
We utilized this in vitro system to determine whether Slug expression by AV canal endothelial cells is dependent on the presence of AV canal myocardium. The AV canal was dissected from stage 14 chicken embryo hearts and cultured on collagen gels for 9 h to allow the endothelial cells to form a tight monolayer on the surface of the gel. The myocardium was then removed from several of the explants. After 24 h of incubation, the explants were stained for Slug. Immunostaining revealed that Slug is expressed by AV canal endothelial cells provided AV canal myocardium remains intact (Fig. 4C) . When the myocardium was removed from the explant before the endothelial cells began to transform into mesenchymal cells, the staining was reduced (Fig. 4B) .
Slug Is Required for Epithelial-Mesenchymal Cell Transformation
We hypothesized that Slug functions during the epithelial-mesenchymal cell transformation that occurs during endocardial cushion formation. The AV canal was dissected from stage 14 chicken embryo hearts and cultured on collagen gels in the presence of antisense Slug oligodeoxynucleotides. After 24 h of incubation, the number of mesenchymal cells that migrated beneath the surface of the collagen gel was counted for each explant. We tested two different antisense oligodeoxynucleotides, A and B, which Nieto et al. (1994) used successfully in initial studies of Slug, as well as two additional antisense oligodeoyxnucleotides, C and D. In order to provide control oligodeoxynucleotides with identical GC compositions, the corresponding sense sequences were reversed. All oligodeoxynucleotides were preincubated with Lipofectamine to facilitate delivery into the cells.
Treatment of AV canal explants with any of four antisense Slug oligodeoxynucleotides resulted in a statistically significant decrease in the number of mesenchymal cells found beneath the surface of the collagen gel after 24 h of incubation compared to explants treated with control oligodeoxynucleotides (Fig. 5) . Specifically, treatment of explants with antisense oligodeoxynucleotide A or B resulted in 81 or 67% fewer mesenchymal cells than explants treated with corresponding control oligodeoxynucleotides, respectively. Antisense oligodeoxynucleotides C and D produced similar results (data not shown). It should be noted that treatment of explants with Lipofectamine, with or without oligodeoxynucleotides, resulted in 26% fewer mesenchymal cells than untreated explants. However, no discernible differences in cell morphology were observed between explants treated with Lipofectamine and untreated explants (data not shown).
Antisense Slug oligodeoxynucleotides prevented initial steps of epithelial-mesenchymal cell transformation including endothelial cell-cell separation (Fig. 6) . That is, the endothelial cells of antisense-treated explants were smaller and tended to remain in tight contact with one another compared to the endothelial cells of control explants (Figs. 6A, 6B, and 6C). A few mesenchymal cells still formed in the presence of antisense Slug oligodeoxynucleotides (Fig.  6F) . The mesenchymal cells of both control and antisensetreated explants migrated into the collagen gel normally (Figs. 6D, 6E , and 6F). We used immunostaining to show that antisense treatment reduced levels of Slug protein expression within AV canal explants. The endothelial cells of explants treated with Lipofectamine alone or with control oligodeoxynucleotides express Slug, as do mesenchymal cells within the collagen gel (Figs. 7A and 7B ). Mesenchymal cells that formed in the presence of antisense Slug oligodeoxynucleotides also express Slug (data not shown). However, staining was significantly reduced within the endothelium of antisense-treated explants (Fig. 7C) , demonstrating that the antisense Slug oligodeoxynucleotides were effective in reducing levels of Slug protein expression. No staining was observed when explants were stained for mouse IgG as a negative control (data not shown).
In addition to immunostaining, we used RT-PCR to show that antisense treatment reduced levels of Slug mRNA expression within AV canal explants. After 24 h of incubation, RNA was isolated from both control and antisensetreated explants and treated with DNase for use in a semiquantitative "kinetic" approach to RT-PCR (Freeman et al., 1999) . Specifically, RT-PCR was performed using specific primers designed to amplify a 358-bp Slug sequence or an 800-bp GAPDH sequence from RNA collected from control explants. A single band of the expected size was detected with each set of primers (data not shown). Twentyseven cycles was determined to be within the linear range of both Slug and GAPDH amplification by removing and analyzing aliquots from a series of cycles (20 -35). RT-PCR was then repeated for 27 cycles using RNA collected from both control and antisense-treated explants. Quantification of Slug band density normalized to GAPDH levels from the same RNA samples demonstrated that antisense treatment resulted in a statistically significant decrease in Slug mRNA expression compared to control explants ( Fig. 8A  and 8B ). In addition, these results suggest that the antisense Slug oligodeoxynucleotides reduced Slug expression levels without affecting the expression of other mRNAs such as GAPDH. No bands were detected when RT-PCR was performed without reverse transcriptase. 
DISCUSSION
In the present study we tested the hypothesis that the transcription factor Slug plays a role in the epithelialmesenchymal cell transformation that occurs in the AV canal of the developing chicken heart. Consistent with this hypothesis, Slug is expressed by AV canal endothelial cells. AV canal endothelial cells continue to express Slug as they transform into mesenchymal cells and migrate into the underlying ECM of the endocardial cushions. Treatment of AV canal explants with antisense Slug oligodeoxynucleotides inhibited mesenchymal cell formation in vitro. Observation of treated explants revealed that antisense Slug oligodeoxynucleotides prevented endothelial cell-cell separation, suggesting that Slug acts early in the transformation pathway. These results are consistent with the fact that NBT-II cells transfected with mouse Slug cDNA were induced to undergo initial steps of epithelial-mesenchymal cell transformation, including desmosome dissociation and cell-cell separation (Savagner et al., 1997) . Although transfection of NBT-II cells with mouse Slug cDNA was not sufficient to trigger later events such as cell motility, a role for Slug in later events during the epithelial-mesenchymal cell transformation of AV canal endothelial cells cannot be ruled out.
Phosphorothioate-modified oligodeoxynucleotides are commonly used to inhibit gene expression and have proven to be effective in many instances (Srivastava et al., 1995; Jiang et al., 1998b) . However, recent studies have raised some concern about the use of oligodeoxynucleotides with this type of modification. For instance, phosphorothioatemodified oligodeoxynucleotides can have sequence-specific but non-antisense effects on growth factors and cell-ECM interactions (Benimetskaya et al., 1995; Guvakova et al., 1995; Rockwell et al., 1997; Stein, 1997) . It is extremely difficult to control for potential non-antisense effects of phosphorothioate-modified oligodeoxynucleotides. Therefore, we opted to use unmodified oligodeoxynucleotides in the present study. We tested the same two antisense oligodeoxynucleotide sequences that Nieto et al. (1994) used in initial studies of Slug, as well as two additional antisense oligodeoxynucleotide sequences. To facilitate their delivery into the targeted AV canal endothelial cells, the unmodified oligodeoxynucleotides were preincubated with Lipofectamine. Liposomal delivery protected the oligodeoxynucleotides from degradation by nucleases present in the ECM.
All four unmodified antisense Slug oligodeoxynucleotides tested proved to be very effective in inhibiting mesenchymal cell formation in vitro when delivered in liposomes. Antisense oligodeoxynucleotides inhibit gene expression by targeting transcripts for degradation by RNase H (Runyan et al., 1999) . Immunostaining and semiquantitative RT-PCR confirmed that the unmodified antisense oligodeoxynucleotides reduced both Slug protein and mRNA levels in the AV canal endothelium despite their shorter half-life relative to phosphorothioate-modified oligodeoxynucleotides. The effectiveness of the unmodified antisense oligodeoxynucleotides may be attibuted to a relatively slow turnover of Slug mRNA following RNase H-mediated degradation of targeted transcripts. Alternatively, there may be only a short period of time during which Slug expression is critical for epithelial-mesenchymal cell transformation; consequently, the explants were not able to recover from loss of Slug expression following exposure to the antisense oligodeoxynucleotides during this time period. Nevertheless, the effectiveness of unmodified oligodeoxynucleotides in our study confirms the antisense function of the phosphorothioate-modified oligodeoxynucleotides used by Nieto et al. (1994) and thereby verifies a role for Slug in gastrulation and neural crest differentiation in chicken embryos. In addition, our antisense approach provides clear evidence that Slug is required for the epithelialmesenchymal cell transformation that occurs in the AV canal.
Despite the presence of antisense Slug oligodeoxynucleotides, a few mesenchymal cells still formed within treated AV canal explants. It is possible that these cells had already begun to undergo epithelial-mesenchymal cell transformation at the time of antisense treatment and no longer required Slug activity. Due to the relatively short half-life of unmodified oligodeoxynucleotides, it also is possible that these cells escaped oligodeoxynucleotide exposure and were able to complete transformation during the interval between applications of oligodeoxynucleotides to the explants. Finally, Slug may be only one of several related transcription factors that play a role in the epithelialmesenchymal cell transformation of AV canal endothelial cells. That is, a related protein such as Snail may have functionally compensated for the lack of Slug protein in these mesenchymal cells. It should be noted that the early developmental expression patterns of Slug and Snail are inverted between chicken and mouse embryos (Sefton et al., 1998) . For example, Snail is expressed in the primitive streak and premigratory neural crest of mouse embryos. Therefore, Snail may be more likely than Slug to play a role in the epithelial-mesenchymal cell transformations that occur during gastrulation and neural crest differentiation in mouse embryos. However, since mouse Slug cDNA is capable of inducing the epithelial-mesenchymal cell transformation of NBT-II cells, Slug and Snail may have at least partially redundant functions during the epithelialmesenchymal cell transformations that occur during mouse and chicken development. Recently, we detected Snail expression in the chicken heart by RT-PCR at developmental stages during which endocardial cushion formation occurs in the AV canal (our unpublished observations). Therefore, it is possible that more than one Snail family member plays a role in the epithelial-mesenchymal cell transformation that occurs during endocardial cushion formation in chicken embryos.
The molecular mechanisms regulating Slug expression during epithelial-mesenchymal cell transformation are poorly understood. However, in the present study we found that removal of the myocardium from AV canal explants resulted in a reduction in Slug expression by AV canal endothelial cells. Therefore, Slug expression within the endothelium appears to be an early response to the myocardially derived signal that initiates endocardial cushion formation in the AV canal. Previous studies have shown that the myocardially derived signal is multifactorial (Moore et al., 1998; Sinning et al., 1997) . TGF␤ appears to be component of this signal (Potts and Runyan, 1989; Potts et al., 1991 Potts et al., , 1992 Nakajima et al. 1994; Brown et al., 1996 , Boyer, 1999a . Treatment of AV canal explants with blocking antibodies specific for TGF␤2 (Boyer et al., 1999a) or the type III TGF␤ receptor (Brown et al., 1999) prevented initial steps of epithelial-mesenchymal cell transformation including endothelial cell-cell separation. We found that treatment of explants with antisense Slug oligodeoxynucleotides had a similar effect on epithelial-mesenchymal cell transformation. Therefore, it is possible that Slug expression within AV canal endothelium may be directly regulated by TGF␤ signaling from the adjacent myocardium. Alternatively, Slug expression may be regulated by a G protein since endothelial cell-cell separation also was inhibited by treatment with pertussis toxin, an inhibitor of G protein function (Boyer et al., 1999b) . Future studies will examine the regulation of Slug activity in AV canal endothelial cells by these signal transduction mechanisms.
Slug is required for the epithelial-mesenchymal cell transformations that occur during several developmental processes in the chicken embryo including gastrulation, neural crest differentiation, and endocardial cushion formation (Nieto et al., 1994 ; the present study). However, Slug may serve additional functions during chicken development besides promoting epithelial-mesenchymal cell transformation. For instance, Slug also is expressed in several non-neural-crest-derived mesenchymal cell populations within the developing lung, kidney, digestive tract, and limb (Buxton et al., 1997; Ros et al., 1997; Savagner et al., 1998) . Slug may act to maintain the mesenchymal phenotype in each of these tissues. In addition, we found by immunostaining that Slug is expressed in the myocardium. Although the reason for Slug expression in this tissue is unknown, it is possible that Slug may play a role in the shape changes that individual myocardial cells undergo during heart looping. Such a role in cell shape change would be consistent with control of cell shape change by Slug during epithelial-mesenchymal cell transformation. Regardless of other potential roles for Slug during development, our findings argue that Slug plays a conserved role in epithelial-mesenchymal cell transformations and provide us with a better understanding of endocardial cushion formation.
